References
Swerdlow SH, Campo E, Harris NL et al (2008) World Health Organization Classification of Tumors: Tumors of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC) Press, Lyon
Shimizu-Kohno K, Kimura Y, Kiyasu J et al (2012) Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases. Pathol Int 62(9):577–582
Mollejo M, Algara P, Mateo MS et al (2002) Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma. Histopathology 40(1):22–30
Kalaszczynska I, Geng Y, Iino T et al (2009) Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 138(2):352–365
Chao Y, Shih YL, Chiu JH et al (1998) Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res 58(5):985–990
Mrena J, Wiksten JP, Kokkola A, Nordling S, Haglund C, Ristimäki A (2006) Prognostic significance of cyclin A in gastric cancer. Int J Cancer 119(8):1897–1901
Paterlini P, Suberville AM, Zindy F et al (1993) Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 53(2):235–238
Wang LH, Huang W, Lai MD, Su IJ (2012) Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis 33(2):466–472
Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma V-M (1999) Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 80(12):2001–2007
Aaltomaa S, Eskelinen M, Lipponen P (1999) Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Prostate 38(3):175–182
Acknowledgments
We thank Pr Brousset from Hopital Purpan (Toulouse, France) for confirming the diagnosis of splenic diffuse red pulp small B cell lymphoma case.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Ben Younes, K., Doghri, R., Mrad, K. et al. Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case. Ann Hematol 96, 511–512 (2017). https://doi.org/10.1007/s00277-016-2860-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-016-2860-2